Your local pharmacy. We provide health advice and services to our community online and over the phone for coronavirus advice, as well as pharmaceutical and health products for purchase online. NZ-wide delivery or click and collect if you're in self-isolation for COVID-19. If urgent, you can also can visit us in store.

Book and collect your products at Farmacia Zucca in Segrate (MI) in via Roma, 8. You can also book via NRE, white and/or veterinary prescription or request home delivery!

Find products and services, compare and quote to buy directly from hospital suppliers and manufacturers. Hospital equipment, hospital instruments, hospital consumables, hospital furniture

Homepage

On September 2, 2019, the Ministry of Civil Affairs approved the renaming of the China Pharmaceutical Enterprises Development Promotion Association to the China Vaccine Industry Association, which will play a more active role in promoting the strengthening of self-discipline in the vaccine industry and guiding enterprises to carry out production and operation in accordance with the law. The China Association for Vaccines (CAV) is a national, industry-based, non-profit national first-level industry association formed voluntarily by enterprises, institutions, social groups and individuals in the vaccine and related biological products industry in accordance with the spirit of the Vaccine Management Law of the People's Republic of China and the Opinions on Reforming and Improving the Vaccine Management System (Zhongbanfa [2018] No. 70), under the leadership and guidance of six ministries and commissions including the Ministry of Industry and Information Technology, the State Administration for Market Regulation, the State Food and Drug Administration, the National Health Commission, the State-owned Assets Supervision and Administration Commission, and the Ministry of Civil Affairs. It is based on the former China Pharmaceutical Enterprises Development Promotion Association and is a national, industry-based, non-profit national first-level industry association with corporate legal person status. The purpose of the association is to serve the Healthy China strategy, adhere to the development concept of taking the people as the center and always putting the people's health first, and promote the development of the vaccine and related biological products industry. Actively participate in industry safety governance, establish and improve industry self-discipline norms, promote the construction of an industry integrity system, guide and urge enterprises to carry out production and operation activities in accordance with the law, and promote self-management, self-regulation, self-purification, and self-improvement throughout the industry. Strengthen communication and coordination between the industry and the government, promote the implementation of industrial policies and relevant laws and regulations, safeguard the legitimate rights and interests of members, maintain fair competition and market order, actively promote scientific and technological innovation, optimize resource allocation, improve product and service quality, and promote industrial upgrading. The association currently has 164 member units, mainly vaccine and biological product research and development, production, circulation, and upstream and downstream related service supporting enterprises, throughout the entire biopharmaceutical industry chain.

CCH Technology Industrial 3D Printer, 3D Printer and Engineering Solutions 3D Printing Solutions 3D Prosthetics and Medical Products Special Medical Printing Solutions.

Narayana, publisher and online shop for homeopathy, naturopathy, healthy nutrition

Centro Diagnostico Sabatino, 20 minutes from Rome, offers diagnostic and prevention services: blood tests, radiological examinations, specialist visits.

About Cell-Innovations Cell-Innovations patented technology Cell-Innovations is an Australian-owned company involved in developing and commercialising cutting-edge regenerative medical technologies. Cell-Innovations is engaged in clinical and basic science studies to test the application of autologous Stromal Vascular Fraction (SVF) for various clinical indications. Cell-Innovations has developed a portfolio of licensed technologies that deliver efficient and reliable […]

Beijing Zhongguancun Science and Technology Development (Holdings) Co., Ltd. (Zhongguancun Science and Technology for short) was established in 1999 and listed on the Shenzhen Stock Exchange. In 2015, Zhongguancun Science and Technology gradually transformed its industrial structure from "technology real estate + medicine" to a development and operation strategy with "medicine and health" as the core. In August 2018, Zhongguancun Science and Technology was recognized by the regulatory authorities, and its industry classification was changed from "comprehensive" to "pharmaceutical manufacturing", and the strategic transformation was initially successful. In August 2021, the company adjusted its development strategy, further focused its positioning, and planned to establish an innovative pharmaceutical industry group focusing on the pharmaceutical field. In July 2024, the company further adjusted its development strategy and is committed to becoming a leading pharmaceutical and health industry service provider.